What is TJM Labs?
TJM Labs operates as a specialized pharmacy AI platform designed to automate complex operational workflows. By integrating intelligent automation into prescription processing and communication, the company effectively reduces the administrative burden on pharmacy teams, allowing them to prioritize patient care. The platform is built by a unique combination of pharmacists and AI engineers, ensuring that the technology is both clinically relevant and technically robust. As a pharmacy-native solution, TJM Labs addresses the specific pain points of modern pharmacy operations, positioning itself as an essential infrastructure provider for healthcare providers seeking to modernize their digital capabilities.
How much funding has TJM Labs raised?
TJM Labs has raised a total of $100M across 2 funding rounds:
Series A
$25M
Series B
$75M
Series A (2026): $25M, investors not publicly disclosed
Series B (2026): $75M led by Elephant, Arthur Ventures, and Updata Partners
Key Investors in TJM Labs
Elephant
Founded in 2015 and based in Boston, Massachusetts, Elephant is a venture capital firm focused on the enterprise software, consumer internet, and mobile markets.
Arthur Ventures
Arthur Ventures is an early growth capital firm that specializes in leading investments in B2B software companies across the U.S. and Canada, focusing on maximizing value in the software sector.
Updata Partners
Updata Partners is a growth equity investment firm specializing in technology-driven enterprises, focusing on software and internet companies that have developed defensible intellectual property and demonstrated market traction.
What's next for TJM Labs?
With the successful completion of this major strategic investment, TJM Labs is poised to transition into a phase of rapid market expansion. The company's focus will likely shift toward scaling its enterprise-level offerings and deepening its integration capabilities within existing pharmacy management systems. By utilizing the recent capital, TJM Labs aims to enhance its AI models, ensuring they remain at the forefront of operational efficiency. Furthermore, the firm is expected to leverage its partnerships with growth-oriented investors to navigate the complexities of the healthcare technology market, ultimately driving sustainable value creation and strengthening its competitive moat in the pharmacy automation sector.
See full TJM Labs company page
